Immvention Therapeutix
Business Services · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5 Laboratory Dr, Durham, North Carolina,...Phone Number
(919) 593-6230Website
www.immventionthera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Immvention Therapeutix
IMMvention Therapeutix specializes in first-in-class Bach1 inhibitors designed as oral therapies for patients with sickle cell disease (SCD) and other conditions. The company collaborates with Novo Nordisk to enhance the transformative potential of its products. Their focus is on developing innovative treatments that address significant medical needs. The company aims to expand its vision and pipeline to improve patient outcomes.Explore more
Immvention Therapeutix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immvention Therapeutix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Immvention Therapeutix
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Immvention Therapeutix is spiking on competitors!
Check if Immvention Therapeutix has recently received funding, and reach out quickly before it becomes old news!
Click to see if Immvention Therapeutix had a recent Job posting/layoffs
Earning: See what the market has to say on Immvention Therapeutix recently announced quarterly report
Product Launch: Get notified when Immvention Therapeutix launches new products
Immvention Therapeutix, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Immvention Therapeutix has new funding data
Recommended Actions
Find VP level buyers at Immvention Therapeutix
Find more new buyers
Compare Similar Companies to Immvention Therapeutix
Compare insights from companies similar to Immvention Therapeutix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immvention Therapeutix
<$5M
1-10
Private
<$5M
2015
MG
Matthew GallovicSenior Director, Research & Development
Company Profile Activity
Activity Insights
Immvention Therapeutix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Immvention Therapeutix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Immvention Therapeutix.
Immvention Therapeutix financials insights
Gather financial insights about Immvention Therapeutix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$3.9M
Immvention Therapeutix Tech Stack
A closer look at the technologies used by Immvention Therapeutix
Immvention Therapeutix News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immvention Therapeutix
Sign Up For FreeTo access detailed company insights
IMMvention Therapeutix specializes in first-in-class Bach1 inhibitors designed as oral therapies for patients with sickle cell disease (SCD) and other conditions. The company collaborates with Novo Nordisk to enhance the transformative potential of its products. Their focus is on developing innovative treatments that address significant medical nee... Read More
